WVE
Wave Life Sciences Ltd. · Healthcare · Market cap $857.2M
Insiders sold $135K net in the last 90 days ·4 sellers, 0 buyers· 4 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 14, 2026
Insider Buying
$82.6M
reported purchases (SEC code P)
Insider Selling
$15.9M
reported sales (SEC code S)
Unique Insiders
13
in the rolling window
Latest filing
Aug 14, 2026
Wagner Heidi L
Wave Life Sciences Ltd. (WVE) has 23 SEC Form 4 filings (86 transaction rows) in the rolling window, disclosed by 13 distinct insiders. Most recent filing: Aug 14, 2026.
Inside the rolling window, 13 insiders at Wave Life Sciences Ltd. reported 5 open-market purchases totaling $82.6M and 20 open-market sales totaling $15.9M. The most active filer is Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. with 4 filings. Insiders have net bought $54.0M over the trailing 6 months. The largest single insider purchase in this window was $32.3M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on Mar 26, 2026. The most recent open-market filing is a sale of 7,000 shares by Director Wagner Heidi L, dated Aug 11, 2026, worth $42K.
- Industry:Biotechnology
- CEO:Paul Bolno
- Employees:317
- HQ:Singapore, CE, SG
- IPO:2015-11-11
| Source | |||||||
|---|---|---|---|---|---|---|---|
Wagner Heidi LFirst in 8 months | Director | Sale | 7,000 | $42K | Aug 14 | -19.6% | SEC ↗ |
Rawcliffe AdrianFirst in 8 months | Director | Sale | 12,700 | $67K | Aug 14 | -19.6% | SEC ↗ |
TAKANASHI KENFirst filing | Director | Sale | 3,864 | $23K | Aug 14 | -19.6% | SEC ↗ |
Tan Aik NaFirst in 8 months | Director | Sale | 432 | $3K | Aug 14 | -19.6% | SEC ↗ |
| Director, 10% Owner | Purchase | 5,305,782 | $32.3M | Mar 30 | -34.3% | SEC ↗ | |
| Director, 10% Owner | Purchase | 2,495,623 | $16.0M | Mar 30 | -34.3% | SEC ↗ | |
| Director, 10% Owner | Purchase | 971,091 | $6.3M | Mar 30 | -34.3% | SEC ↗ | |
| See Remarks | Sale | 33,194 | $500K | Feb 27 | -68.8% | SEC ↗ | |
Vargeese ChandraFirst filing | See Remarks | Sale | 3,228 | $43K | Feb 11 | — | SEC ↗ |
| See Remarks | Sale | 1,883 | $25K | Feb 11 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,588 | $48K | Feb 11 | — | SEC ↗ | |
BOLNO PAULFirst filing | President and CEO | Sale | 10,480 | $141K | Feb 11 | — | SEC ↗ |
| See Remarks | Sale | 9,375 | $150K | Jan 6 | — | SEC ↗ | |
GSK plcFirst filing | 10% Owner | Purchase | 1,470,000 | $27.9M | Dec 15 | — | SEC ↗ |
Moran KyleFirst filing | Chief Financial Officer | Sale | 210,000 | $3.1M | Dec 10 | — | SEC ↗ |
Moran KyleFirst filing | Chief Financial Officer | Sale | 50,036 | $1.0M | Dec 10 | — | SEC ↗ |
Francis ChrisFirst filing | See Remarks | Sale | 441,031 | $6.4M | Dec 10 | — | SEC ↗ |
Tan Aik NaFirst filing | Director | Sale | 113,218 | $1.6M | Dec 10 | — | SEC ↗ |
HENRY CHRISTIAN OFirst filing | Director | Sale | 93,445 | $1.4M | Dec 10 | — | SEC ↗ |
Wagner Heidi LFirst filing | Director | Sale | 14,000 | $189K | Dec 10 | — | SEC ↗ |
| Director | Sale | 42,000 | $630K | Dec 10 | — | SEC ↗ | |
CORRIGAN MARKFirst filing | Director | Sale | 16,115 | $217K | Dec 10 | — | SEC ↗ |
Verdine Gregory L.First filing | Director | Sale | 20,000 | $269K | Dec 10 | — | SEC ↗ |
Rawcliffe AdrianFirst filing | Director | Sale | 16,115 | $109K | Nov 14 | — | SEC ↗ |
| Director, 10% Owner | Purchase | 1,000 | $7K | Nov 14 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does WVE have?
Wave Life Sciences Ltd. (WVE) has 23 SEC Form 4 filings (86 transaction rows) in the rolling 365-day window, disclosed by 13 distinct insiders. Most recent filing: Aug 14, 2026.
When was the most recent SEC Form 4 filing for WVE?
The most recent Form 4 filing for WVE on Tracefour is dated Aug 14, 2026.
Who is the most active insider at WVE?
The most active SEC Form 4 filer at WVE in the rolling window is Director, 10% Owner RA CAPITAL MANAGEMENT, L.P., with 4 filings.
What is the net insider flow at WVE over the last 6 months?
Over the trailing 180 days, insiders at WVE have net bought $54.0M based on SEC Form 4 disclosures.
What was the largest insider purchase at WVE?
The largest single insider open-market purchase at WVE in the rolling window was $32.3M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on 2026-03-26.
What is the total insider buy and sell value at WVE in the current window?
Inside the rolling window, insiders at WVE bought $82.6M and sold $15.9M based on SEC Form 4 filings.
Can I get alerts for WVE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Wave Life Sciences Ltd. (WVE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Wave Life Sciences Ltd. is in the Healthcare sector.